Article
A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma
8 Feb 2023
Abstract excerpt
Background: Nicotinamide adenine dinucleotide (NAD+) metabolism is involved in a series of cancer pathogenesis processes, and is considered a promising therapeutic target for cancer treatment. However, a comprehensive analysis of NAD+ metabolism events on immune regulation and cancer survival has not yet been conducted. Here, we constructed a prognostic NAD+ metabolism-related gene signature (NMRGS) associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
